abstract |
The present disclosure provides methods for treating diseases such as neurodegenerative and neuroinflammatory diseases, for example, Alzheimer's disease, comprising administration of a CTLA-4-containing protein, e.g., abatacept, and an IL-2 protein, e.g., aldesleukin, to a subject, either separately or in a single formulation. Also presented herein are pharmaceutical compositions comprising a CTLA-4-containing protein, e.g., abatacept, and an IL-2 protein, e.g., aldesleukin. |